Results Update from the DRIVE PK Study: Effects of AG-348, a Pyruvate Kinase Activator, in Patients with Pyruvate Kinase Deficiency

Rachael F. Grace, Bertil Glader, F. Galactéros et al.|Blood|2017

Cited by 2